HomeAI · summaries
Storia in 5 fonti
Novo Nordisk Advances Weight-Loss Portfolio With UK Approval Of Wegovy Tablet - Novo Nordisk (NYSE:NVO)
Novo Nordisk wins U.K. approval for Wegovy pill, offering adults a daily oral weight-loss option backed by Phase 3 trial data.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
dailymail.com
Wegovy Pill weight-loss drug approved for use in Britain
As exclusively revealed by the Daily Mail last week, the Wegovy Pill - the tablet form of the once-weekly Wegovy injection - has been greenlit by health officials.
- ·
theguardian.com
Wegovy weight-loss pills to be available for patients in UK to buy
Regulator approval means patients who meet criteria such as having obesity will be able to purchase pills with private prescription
